Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 09, 2023

SELL
$1.07 - $1.34 $46 - $57
-43 Reduced 0.29%
15,000 $0
Q1 2022

Apr 21, 2022

BUY
$2.85 - $3.73 $122 - $160
43 Added 0.29%
15,043 $49,000
Q4 2021

Feb 15, 2022

BUY
$3.24 - $5.18 $48,600 - $77,700
15,000 New
15,000 $51,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Cwa Asset Management Group, LLC Portfolio

Follow Cwa Asset Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.